Oncobesity News Posts

Blood Thinners & Anti-Obesity Shots Dominate Medicare Drug Spending
Blood Thinners & Anti-Obesity Shots Dominate Medicare Drug Spending From diabetes injectables to blockbuster blood thinners, a handful of drugs account for a sizable share

A MARKETING BOON FOR GLP-1 DRUGS: “Astounding” – 70% of Americans Have Obesity by New, More A
A MARKETING BOON FOR GLP-1 DRUGS: “Astounding” – 70% of Americans Have Obesity by New, More Accurate Definition. Weirdly, more people need blood pressure drugs

Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S on The Analyst’s Journal’s Substack by A_Capital. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk

The Stupidest Thing in American Health Care? Failing to Tackle Obesity Early.
It takes a very particular kind of political brainworm to look at a country where nearly half the population is obese, where Medicare and Medicaid

Semaglutide helps heart regardless of how much weight lost, study reveals
Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a UCL researcher.

SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.
SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.

GLP-1 Medications, Like Ozempic, May Help To Slow Or Even Reverse Aging According To New Study
Shutterstock GLP-1 drugs such as Ozempic have been shown to be extremely effective at helping diabetics manage their blood sugar, and almost anyone else to
STAT+: Pharmalittle: We’re reading about a new Trump drug-pricing probe, Novo’s board shake-up, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more

STAT+: Novo Foundation ousts board in power struggle
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we talk

Why Everything From Perfume to Soap Smells Like Food Now
As demand for products scented like vanilla, pistachio and other edible indulgences soars, some GLP-1 users say there’s a link to their changed eating habits.

Among T2D Drugs, GLP-1s Top Others for Reducing CV Events
A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against cardiovascular events, followed by SGLT2i and two older drug classes.

More and more workers are using weight loss drugs. It’s costing their employers a fortune – CNN
More and more workers are using weight loss drugs. It’s costing their employers a fortune CNN Ozempic for All The Atlantic Lopez: Expanding access to anti-obesity drugs

STAT+: Companies tout a novel payment model for obesity drugs, other medications in drive to lower costs
As pharma companies and President Trump tout initiatives to sell branded medications directly to cash-paying consumers, some entrepreneurs have seized on a potential business opportunity

Coke Is Leaning Into the Protein Craze as It Lands in More Drinks, Snacks—and Pet Foods
Beata Zawrzel / NurPhoto via Getty Images Coca-Cola is ramping up production of high-protein milks. Key Takeaways Coca-Cola is leaning into its high-protein milk products,

GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked

Healthy Returns: A key step forward for Novo Nordisk’s GLP-1 pill
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.

GLP-1 Drugs May Manage Weight Recurrence After Bariatric Surgery
Glucagon-like peptide-1 (GLP-1) receptor agonists may support weight management in patients following bariatric surgery. A study suggests that GLP-1 drug use is particularly common among

NVO’s Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients
Novo Nordisk NVO received FDA approval for a regulatory application seeking the label expansion of its oral GLP-1 drug, Rybelsus (semaglutide), to include cardiovascular (CV) risk reduction
Study finds GLP-1 drugs may help prevent risks from sleep apnea
GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, researchers wrote in a new study.

American Airlines Drops Ozempic Coverage, Flight Attendants Push Back
Ozempic may still be flying high in America, but not in American Airlines’ employee health plan. American Airlines Cuts Ozempic From Flight Attendant Healthcare Coverage

GLP-1 Drugs Help Protect Against Sleep Apnea, Study Says
By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect…

Did Eli Lilly Just Say “Checkmate” to Novo Nordisk?
Key Points Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly’s recent clinical progress sets it up

West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum

Colleges Push Back, Ozempic Price Promise, and White House vs. Anthropic
Kara and Scott discuss more schools saying no to Trump’s college “compact,” the No Kings protests, and the AWS outage. Then, Trump’s promise to slash

GLP-1 Drugs, Such as Ozempic, Zepbound, Help Protect Against Sleep Apnea, Study Says
TUESDAY, Oct. 21, 2025 — Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says.
Type 2 diabetes patients taking GLP-1 drugs were overall less likely to die within the…

How Medical Aesthetics Practices Are Driving GLP-1 Usage Amidst Ongoing Regulatory Changes
A look at GLP-1 spend at medical aesthetics practices from 2021 to 2025, per data and analytics firm Guidepoint Qsight.

‘Awkward Moment’: Dr. Oz Interrupts Trump at Oval Office
(MedPage Today) — In what some news reports dubbed “an awkward moment,” CMS Administrator Mehmet Oz, MD, stepped up to the podium in the Oval

FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
(MedPage Today) — The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with diabetes, whether or not they’ve

Mortality down with GLP-1 receptor agonist use in T2D, especially in those with OSA
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive

CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With OSA
MONDAY, Oct. 20, 2025 — Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially

American Airlines Cuts Ozempic From Flight Attendant Healthcare Coverage
American Airlines’ flight attendant union is expressing frustration over an upcoming change to the company’s healthcare plan, as flagged by PYOK. I’m curious to see

Can Sculptra reverse GLP-1-related facial ageing? Experts say yes
New data presented at AMWC Dubai highlights Sculptra’s regenerative effects and its synergy with Restylane to address GLP-1-related facial ageing. Discover expert insights and clinical

Supreme bets on GLP-1 users with SlimFast acquisition
Post Content

GLP-1 drug approvals: A breakdown
As of Oct. 17, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications.

How GLP-1 drugs are supercharging the age of precision nutrition
As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop precision nutrition solutions – using AI and

The GLP-1 Economy Is Crashing. CVS Ventures Is Quietly Building What Comes Next
As the GLP-1 economy cools, CVS Ventures leads a $25 million round in Knownwell — betting on physician-led obesity care and payer-backed innovation.

Could functional foods replace the need for GLP-1s?
Explore how functional ingredients are challenging GLP-1 drugs in weight management – and what this shift means for food and beverage innovation.

Ozempic for All
An estimated 100 million adult Americans—more than 40 percent of the population—are classified as obese. This is a massive health crisis that will claim many
What FEHB changes mean for your 2026 health coverage
<
GLP-1 Weight-loss Drugs May Reduce Alcohol Cravings
Post Content